PlainRecalls
FDA Drug Moderate Class II Terminated

Lamotrigine Extended-Release Tablets, USP, 200 mg, 30 tablets per bottle, Rx Only, Manufactured in INDIA, For: TORRENT PHARMA INC., 150 Allen Road, Suite 102, Basking Ridge, NJ 07920. NDC: 13668-342-30

Reported: September 26, 2018 Initiated: September 11, 2018 #D-1204-2018

Product Description

Lamotrigine Extended-Release Tablets, USP, 200 mg, 30 tablets per bottle, Rx Only, Manufactured in INDIA, For: TORRENT PHARMA INC., 150 Allen Road, Suite 102, Basking Ridge, NJ 07920. NDC: 13668-342-30

Reason for Recall

Failed Dissolution Specifications: Out of Specification for Dissolution test (Buffer Stage) at the 5-hour time point during stability testing.

Details

Recalling Firm
Torrent Pharma Inc.
Units Affected
15,384 30-count bottles
Distribution
Nationwide USA
Location
Kalamazoo, MI

Frequently Asked Questions

What product was recalled?
Lamotrigine Extended-Release Tablets, USP, 200 mg, 30 tablets per bottle, Rx Only, Manufactured in INDIA, For: TORRENT PHARMA INC., 150 Allen Road, Suite 102, Basking Ridge, NJ 07920. NDC: 13668-342-30. Recalled by Torrent Pharma Inc.. Units affected: 15,384 30-count bottles.
Why was this product recalled?
Failed Dissolution Specifications: Out of Specification for Dissolution test (Buffer Stage) at the 5-hour time point during stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 26, 2018. Severity: Moderate. Recall number: D-1204-2018.